MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans

C.M. Chevalier, L. Krampert, M. Schreckenbach, C.F. Schubert, J. Reich, B. Novak, M.V. Schmidt*, B.P.F. Rutten, U. Schmidt*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)20-32
Number of pages13
JournalEuropean Neuropsychopharmacology
Volume51
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • Post-traumatic stress disorder
  • Trier Social Stress Test (TSST)
  • Dexamethasone suppression test
  • Mouse model of PTSD
  • PTSD biomarkers
  • exposure therapy
  • POSTTRAUMATIC-STRESS-DISORDER
  • SERUM CONCENTRATIONS
  • PERIPHERAL-BLOOD
  • GENE-EXPRESSION
  • TNF-ALPHA
  • MATRIX-METALLOPROTEINASE-9
  • MOUSE
  • DEXAMETHASONE
  • BIOMARKERS
  • GLUCOCORTICOIDS

Cite this